COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 14th April 2020. As a result, our offices will now be closed till 14th April 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details. editor@innovativepublication.com, rakesh.its@gmail.com, Mob. 8826373757, 8826859373, 9910947804

Article view: 456

Article download: 147

IP Archives of Cytology and Histopathology Research


A rare encounter with primary cutaneous mucinous carcinoma on cytology


Full Text PDF Share on Facebook Share on Twitter


Author Details : Pooja S. Kala*, Harish Chandra

Volume : 3, Issue : 3, Year : 2018

Article Page : 156-169


Suggest article by email

Abstract

Primary cutaneous mucinous carcinoma is a rare adnexal neoplasm of eccrine origin. Most of the cutaneous mucinous carcinomas are metastatic, commonly from gastrointestinal tract and breast. Primary cutaneous mucinous carcinoma was first described in 1952. Only about 200 cases are reported in literature till date. Only a couple of case reports describing the cytological features are available. We report a case of a 70 years old male presenting with nodular lesion on cheek, which was cytologically diagnosed as mucinous neoplasm and later on confirmed on histology and histochemistry to be primary cutaneous mucinous carcinoma. A thorough radiological and clinical workup to rule out the possibility of metastatic deposit of mucinous carcinoma was done.

Keywords: Primary cutaneous mucinous carcinoma, Eccrine, Metastatic.

Doi : 10.18231/2456-9267.2018.0032

How to cite : Kala P S, Chandra H, A rare encounter with primary cutaneous mucinous carcinoma on cytology. IP Arch Cytol Histopathol Res 2018;3(3):156-169

Copyright © 2018 by author(s) and IP Arch Cytol Histopathol Res. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (creativecommons.org)